Prostate Cancer - Results from #26440

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer - Abstract March 13, 2012

High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: A 7-year experience - Abstract March 12, 2012

Patients and partners lack knowledge of androgen deprivation therapy side effects - Abstract March 12, 2012

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial - Abstract March 12, 2012

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy - Abstract March 12, 2012

Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: A systematic review of the literature - Abstract March 12, 2012

Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4Gy per fraction - Abstract March 9, 2012

Temporal changes in quality of life after prostate carcinoma - Abstract March 9, 2012

Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancer - Abstract March 9, 2012

Salvage prostatectomy post-definitive radiation therapy: The Vancouver experience - Abstract March 9, 2012

Detrusor underactivity is prevalent after radical prostatectomy: A urodynamic study including risk factors - Abstract March 9, 2012

Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy - Abstract March 8, 2012

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer - Abstract March 8, 2012

Pursuit of sexual function post-radical prostatectomy - Abstract March 8, 2012

Dutasteride in localised prostate cancer management: The REDEEM randomised, double-blind, placebo-controlled trial - Abstract March 8, 2012

Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: Performance of MR imaging in a multi-reader environment - Abstract March 8, 2012

Advances in imaging the neurovascular bundle - Abstract March 7, 2012

Focal therapy for the treatment of localized prostate cancer: A potential therapeutic paradigm shift awaiting better imaging - Abstract March 7, 2012

The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: A population-based analysis - Abstract March 7, 2012

Postoperative radiotherapy in prostate cancer: The case of the missing target - Abstract March 7, 2012

Page 1323 of 1447